SKIN - The Beauty Health Company
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$1.53
DETAILS
HIGH:
$2.00
LOW:
$1.00
MEDIAN:
$1.60
CONSENSUS:
$1.53
UPSIDE:
122.48%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 300.8 | 334.3 | 398.0 | 365.9 | 260.1 | 119.1 | 166.6 | 112.3 |
| Cost of Revenue | 104.4 | 152.0 | 242.9 | 117.1 | 81.5 | 51.9 | 60.1 | 39.3 |
| Gross Profit | 196.4 | 182.3 | 155.1 | 248.8 | 178.5 | 67.2 | 106.5 | 73.0 |
| Operating Expenses | ||||||||
| R&D Expenses | 5.6 | 6.3 | 10.1 | 8.4 | 8.2 | 3.4 | 4.6 | 2.4 |
| SG&A Expenses | 211.5 | 243.8 | 275.9 | 266.2 | 210.3 | 81.0 | 88.4 | 60.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) |
| Operating Expenses | 217.2 | 250.1 | 286.0 | 274.6 | 218.5 | 84.4 | 93.0 | 62.9 |
| Operating Income | ||||||||
| Operating Income | (20.8) | (67.8) | (130.9) | (25.8) | (39.9) | (17.2) | 13.5 | 10.1 |
| Interest Expense | 19.3 | 10.4 | 13.6 | 13.4 | 11.8 | 21.3 | 17.1 | 10.0 |
| Interest Income | 9.0 | 16.6 | 23.2 | 9.2 | 0.0 | 0 | 0 | 0 |
| Profitability | ||||||||
| EBITDA | 38.7 | 10.3 | (53.6) | 81.6 | (350.9) | (2.8) | 27.9 | 21.6 |
| EBIT | 13.4 | (19.1) | (88.2) | 58.7 | (368.9) | (17.2) | 14.2 | 10.1 |
| Income Before Tax | (5.9) | (29.6) | (101.9) | 45.3 | (380.6) | (38.5) | (2.9) | 0.0 |
| Income Tax Expense | 3.6 | (0.5) | (1.8) | 1.1 | (1.9) | (9.3) | (1.3) | 0.3 |
| Net Income | (9.5) | (29.1) | (100.1) | 44.2 | (378.8) | (29.2) | (1.6) | (0.3) |
| Per Share Data | ||||||||
| EPS (Basic) | -0.08 | -0.23 | -0.76 | 0.30 | -3.67 | -0.85 | -0.05 | -0.00 |
| EPS (Diluted) | -0.16 | -0.36 | -0.76 | -0.23 | -3.67 | -0.85 | -0.05 | -0.00 |
| Shares Outstanding | 126.4 | 123.8 | 131.7 | 147.6 | 102.1 | 34.3 | 32.1 | 125.4 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 232.7 | 370.1 | 523.0 | 568.2 | 901.9 | 9.5 | 7.3 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 23.4 | 28.5 | 55.0 | 77.8 | 51.4 | 23.2 | 23.7 |
| Inventory | 48 | 69.1 | 91.3 | 109.7 | 35.3 | 23.2 | 19.4 |
| Other Current Assets | 5.4 | 9.5 | 28.9 | 27.6 | 0 | 2.6 | 0 |
| Total Current Assets | 309.5 | 477.1 | 698.3 | 783.3 | 1,000.9 | 59.1 | 54.2 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 14.1 | 19.6 | 26.3 | 33.8 | 31.2 | 9.2 | 10.8 |
| Goodwill | 126.6 | 123.5 | 125.8 | 124.6 | 123.7 | 98.5 | 98.5 |
| Intangible Assets | 35.8 | 47.5 | 62.1 | 46.4 | 56.0 | 50.9 | 60.3 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11.9 | 14.1 | 16.0 | 14.2 | 6.7 | 4.8 | 2.3 |
| Total Non-Current Assets | 190.3 | 208.6 | 230.9 | 219.8 | 217.9 | 163.7 | 172.2 |
| Total Assets | 499.8 | 685.7 | 929.1 | 1,003.1 | 1,218.8 | 222.8 | 226.4 |
| Current Liabilities | |||||||
| Account Payables | 15.6 | 21.9 | 44.8 | 28.5 | 29.0 | 18.5 | 14.3 |
| Short-Term Debt | 129.1 | 0 | 0 | 0 | 0 | 0.5 | 8.9 |
| Deferred Revenue | 0 | 2.4 | 0.5 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 40.4 | 2.1 | 25.0 | 5.6 | 18.3 | 2.5 | 0 |
| Total Current Liabilities | 186.3 | 68.2 | 115.0 | 71.7 | 76.4 | 30.9 | 37.8 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 240.4 | 552.2 | 738.4 | 734.1 | 729.9 | 216.0 | 180.8 |
| Deferred Tax Liabilities | 0.4 | 0.4 | 0.7 | 2.0 | 3.6 | 4.0 | 8.3 |
| Other Non-Current Liabilities | 2.4 | 2.3 | 6.3 | 15.5 | 93.8 | 1.9 | 0.3 |
| Total Non-Current Liabilities | 252.5 | 565.7 | 754.7 | 764.3 | 840.1 | 221.9 | 189.7 |
| Total Liabilities | 438.7 | 633.9 | 869.7 | 836.0 | 916.5 | 252.8 | 227.6 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 |
| Retained Earnings | (517.5) | (508.0) | (478.9) | (378.8) | (418.7) | (43.6) | (14.4) |
| Accumulated Other Comprehensive Income | (1.4) | (7.0) | (3.0) | (4.5) | (1.3) | 0.2 | 0.0 |
| Total Stockholders' Equity | 61.1 | 51.8 | 59.4 | 167.1 | 302.3 | (30.0) | (1.2) |
| Total Liabilities & Equity | 499.8 | 685.7 | 929.1 | 1,003.1 | 1,218.8 | 222.8 | 226.4 |
| Debt Metrics | |||||||
| Total Debt | 378.7 | 568.2 | 752.3 | 751.8 | 746.4 | 216.5 | 190.2 |
| Net Debt | 146 | 198.1 | 229.3 | 183.6 | (155.5) | 207.1 | 182.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (9.5) | (29.1) | (100.1) | 44.4 | (375.1) | (29.2) | (1.6) | (0.3) |
| Depreciation & Amortization | 0 | 33.7 | 34.7 | 22.0 | 21.1 | 14.4 | 13.9 | 11.5 |
| Stock-Based Compensation | 0 | 26.7 | 22.5 | 28.5 | 12.4 | 0.4 | 0.1 | 0.1 |
| Change in Working Capital | 10.4 | (27.4) | 23.4 | (140.3) | (18.7) | (2.6) | (7.9) | (9.8) |
| Other Non-Cash Items | 36.6 | 16.0 | 41.3 | (59.4) | 335.6 | 8.9 | 1.9 | 0.7 |
| Operating Cash Flow | 37.5 | 16.1 | 21.8 | (106.6) | (28.4) | (12.4) | 1.7 | (0.9) |
| Investing Activities | ||||||||
| Capital Expenditure | (0.3) | (6.8) | (13.0) | (17.4) | (15.6) | (3.8) | (10.4) | (7.9) |
| Acquisitions | 0 | 0 | (18.5) | (1.5) | (22.9) | 0 | (2.1) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0.8 | 0 | 0 | (0.6) |
| Investing Cash Flow | (5.2) | (6.8) | (31.5) | (18.9) | (37.7) | (3.8) | (12.5) | (8.4) |
| Financing Activities | ||||||||
| Net Debt Issuance | (173.4) | (156.1) | 0 | 0 | 524.5 | 19.7 | 16.5 | 113.6 |
| Stock Repurchased | 0 | (2.0) | (32.4) | (160) | 0 | (0.2) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (98.7) |
| Other Financing Activities | 0.0 | (0.3) | (1.8) | (45.2) | (503.9) | (1.3) | (1.9) | (3.8) |
| Financing Cash Flow | (174.9) | (158.3) | (37.4) | (205.2) | 959.0 | 18.3 | 14.6 | 11.2 |
| Cash Position | ||||||||
| Net Change in Cash | (137.4) | (153.0) | (45.2) | (333.7) | 892.4 | 2.2 | 3.7 | 1.8 |
| Cash at Beginning | 370.1 | 523.0 | 568.2 | 901.9 | 9.5 | 7.3 | 3.6 | 1.8 |
| Cash at End | 232.7 | 370.1 | 523.0 | 568.2 | 901.9 | 9.5 | 7.3 | 3.6 |
| Free Cash Flow | 37.2 | 9.3 | 8.7 | (124.0) | (44.0) | (16.3) | (8.7) | (8.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 300.8 | 334.3 | 398.0 | 365.9 | 260.1 | 119.1 | 166.6 | 112.3 |
| Gross Profit | 196.4 | 182.3 | 155.1 | 248.8 | 178.5 | 67.2 | 106.5 | 73.0 |
| Operating Income | (20.8) | (67.8) | (130.9) | (25.8) | (39.9) | (17.2) | 13.5 | 10.1 |
| Net Income | (9.5) | (29.1) | (100.1) | 44.2 | (378.8) | (29.2) | (1.6) | (0.3) |
| EPS (Diluted) | -0.16 | -0.36 | -0.76 | -0.23 | -3.67 | -0.85 | -0.05 | -0.00 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 232.7 | 370.1 | 523.0 | 568.2 | 901.9 | 9.5 | 7.3 | |
| Total Assets | 499.8 | 685.7 | 929.1 | 1,003.1 | 1,218.8 | 222.8 | 226.4 | |
| Total Debt | 378.7 | 568.2 | 752.3 | 751.8 | 746.4 | 216.5 | 190.2 | |
| Stockholders' Equity | 61.1 | 51.8 | 59.4 | 167.1 | 302.3 | (30.0) | (1.2) | |
| Cash Flow | ||||||||
| Operating Cash Flow | 37.5 | 16.1 | 21.8 | (106.6) | (28.4) | (12.4) | 1.7 | (0.9) |
| Capital Expenditure | (0.3) | (6.8) | (13.0) | (17.4) | (15.6) | (3.8) | (10.4) | (7.9) |
| Free Cash Flow | 37.2 | 9.3 | 8.7 | (124.0) | (44.0) | (16.3) | (8.7) | (8.8) |